COH -2.01%: the hearing implants company’s 1H was largely pre-announced at a trading update last week, Cochlear pulled back from all-time highs hit on Friday on slight cracks showing in the numbers. Implant revenue growth was the main driver of a solid first half, slightly offset by softness in the smaller Services & Acoustics segment. The company upgraded guidance in a trading update earlier in the month, however, it looks as though much of the improvement came from FX assumptions while costs are expected to weigh on margins. The company also paused their buyback, citing the macro environment.
MM remains neutral COH
Add To Hit List
